Repositioning the future of evar real life experience with the gore excluder featuring c3 delivery system and one year results of the european registry
Repositioning the future of evar real life experience with the gore excluder featuring c3 delivery system and one year results of the european registry
Similar to Repositioning the future of evar real life experience with the gore excluder featuring c3 delivery system and one year results of the european registry
Various heat treated ni ti rotary instrtuments evaluated-in-s-shpaed-simulate...luis Cabrera Piña
Similar to Repositioning the future of evar real life experience with the gore excluder featuring c3 delivery system and one year results of the european registry (20)
Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...
Repositioning the future of evar real life experience with the gore excluder featuring c3 delivery system and one year results of the european registry
28. Confidence
Take on challenging aortic neck anatomy
Angulated long
Angulated short
Straight short
Train future endovascular surgeons
Introduce surgeons experienced in open AAA surgeons to EVAR
Allow experienced endovascular surgeons to take on challenging
anatomy
32. C3 ADDRESSESTHE INABILITYOF BEING ABLETO RELIABLY PREDICT
THE EXACT LANDING SITE OF A GRAFTWITHIN A CURVED SEGMENT
33.
34.
35.
36. Site
Number Site Name
Procedure Date
Range
C3 Deployment
System
203 Klinikum Nürnberg Süd 08/10 - 10/11 40(24.2%)
209 University of Cologne University Clinics 09/10 - 09/11 17(10.3%)
215 Klinikum der Universität Regensburg 08/10 - 08/11 12(7.3%)
218 University of Heidelberg 03/11 – 8/11 8(4.8%)
263 Hospital Clinic I Provincial de Barcelona 09/10 – 6/11 5(3.0%)
264 Orebro University Hopsital 9/10 – 6/11 16(9.5%)
278 Aberdeen Royal Infirmary 9/10 – 10/11 32(19.0%)
279 Cambridge University Hospitals NHS Trust 09/10 - 09/11 13(7.9%)
280 Royal Liverpool University Hospital 09/10 – 10/11 16(9.7%)
283 Weißeritztal Kliniken GmbH 08/10 - 05/11 9(9.5%)
Total Subjects Enrolled 08/10 - 10/11 168
37. C3 Device
N (C3) / N (ABD) =168(%)
%Male 85 / 87
Age (yrs)
Mean (Std Dev) 73.7 / 74 (7.7)
Median 75.0
Range (51.0-90.0)
Patient demographics & surgical risk factors
ASA Classification NYHA Classification
Number Responding 162 Number Responding 161
I 3 / (1.9) I 28(18.0)
II 52(32.1 / 10) II 89(55.3)
III 100(61.7 / 70) III 29(18.0)
IV 7(4.3 / 10) IV 0(0.0)
V 0(0.0) No Cardiac Disease 14(8.7)
38. N=161(%)
Aortic Pathology
Abdominal aortic aneurysm 157(97.5 / 100)
Common iliac aneurysm 3(1.9)
Abdominal aortic aneurysm rupture 1(0.6)
Reason for Treatment
Primary Procedure for Endovascular Treatment 155(96.3 / 100)
Reintervention of an Open Surgical Procedure 3(1.9)
Reintervention of a Prior Endovascular Procedure 2(1.2)
39. Aneurysm Diameter (mm)
n 155
Mean (Std Dev) 58.4(60)
Median 56.0
Range (35.0,95.0)
Proximal Neck Length (cm)
n 154
Mean (Std Dev) 2.9 (2.1)
Median 2.5
Range (0.3,21.0)
Infrarenal Neck Angle
n 147
Mean (Std Dev) 27.7(24.4)
Median 22.0
Range (0.0,100.0)
Case Planning
Information
Neck Length < 1.5 cm 13(8.1%)
Neck Angulation ≥ 60 15(9.3%)
Significant Calcification at
Landing Zones
28(17.4%)
Significant Thrombus at
Landing Zones
18(11.2%)
40. Anesthesia Method n (%)
General 149 (92.5 / 100)
Regional 11(6.8)
Local 0
Procedure Survival 161(100 / 100)
Procedure Time (skin-to-skin)
Mean (Std Dev) 126.7(65.4 / 70)
Median 110.0
Range (60.0,477.0)
Hospital Stay (Days)
Mean (Std Dev) 6.6(8.1 / 3)
Median 5.0
Range (1.0,93.0)
41. Number of Enrolled Subjects n=168(%)
Number of Cases Requiring Trunk Repositioning 91/8(57)
Reasons for Repositioning
Positioning Closer to Renal Arteries 67 / 7(42)
Contralateral Gate Positioning 27(17)
Other 16(10)
42. Number of cases requiring repositioning n=95
Number of Repositions per Case
1 61 (7)
2 24(1)
3 5
4 1
Missing 4
43. Number of Enrolled Subjects 168 (%)
95% CI1
Device Deployed Where Planned 150(93 / 100) (88.2%,96.1%)
Deployed ≥5mm from intended location 4(2.5%) (1.0%,6.2%)
44. Number of Enrolled Subjects n=168 (%)
Subjects with Aortic Extender(s) Implanted 8 / 2 (5.0)
Subjects with unplanned Aortic Extender(s) 7 (4.3)
Reasons for Unplanned Extender Use
Increase Seal 1 (0.6)
Extend Landing Zone 1 (0.6)
Type I Endoleak 5 (3.1)
45. Number of Enrolled Subjects n=168 (%)
Any In-Hospital Serious Event 4 / 0 (2.4)
Iliac artery occlusion 2 (1.2)
Device Dislocation 1 (0.6)
Renal haemorrhage 1 (0.6)
Surgical mortality = 0
30 day mortality = 0
Death reported at day 35 due to renal sepsis from dialysis
Death reported at day 173 due to subdural hematoma
47. Controlled delivery
Controlled and precise adjustments in a vertical plane
Controlled orientation of contra-lateral limb in a horizontal
plane
Controlled proximal landing at preferred site avoiding
calcium plaques / thrombus/preserving accessory renals
Controlled proximal landing within a angled neck
Controlled and safe training
Controlled constraint and disengagement of hooks
Controlled use of aortic cuffs / expenses
48. If not the first time certainly by the third repositioning you will
achieve your intended proximal landing site